Zacks Research Weighs in on Danaher’s Q2 Earnings (NYSE:DHR)

Danaher Co. (NYSE:DHR) – Zacks Research lowered their Q2 2025 earnings per share (EPS) estimates for shares of Danaher in a research report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates that the conglomerate will post earnings per share of $1.77 for the quarter, down from their previous forecast of $1.85. The consensus estimate for Danaher’s current full-year earnings is $7.63 per share. Zacks Research also issued estimates for Danaher’s Q3 2025 earnings at $1.86 EPS, FY2025 earnings at $7.62 EPS, Q1 2026 earnings at $1.86 EPS, Q2 2026 earnings at $2.05 EPS, Q3 2026 earnings at $2.06 EPS, Q4 2026 earnings at $2.54 EPS, FY2026 earnings at $8.51 EPS and FY2027 earnings at $9.43 EPS.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the previous year, the firm posted $2.09 EPS.

DHR has been the topic of a number of other research reports. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price on the stock. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price on the stock in a report on Friday, December 13th. Jefferies Financial Group decreased their price objective on Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Finally, Citigroup decreased their price objective on Danaher from $285.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 30th. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Price Performance

Shares of NYSE:DHR opened at $209.86 on Friday. The business’s fifty day moving average price is $226.71 and its two-hundred day moving average price is $246.96. The stock has a market cap of $151.58 billion, a PE ratio of 39.75, a price-to-earnings-growth ratio of 2.66 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher has a one year low of $196.80 and a one year high of $281.70.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. Kovack Advisors Inc. raised its position in Danaher by 3.4% in the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock valued at $346,000 after purchasing an additional 41 shares during the period. Gilbert & Cook Inc. raised its position in Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after purchasing an additional 42 shares during the period. Grimes & Company Inc. increased its position in shares of Danaher by 0.6% during the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after acquiring an additional 43 shares during the last quarter. Harbour Investments Inc. increased its position in shares of Danaher by 3.0% during the third quarter. Harbour Investments Inc. now owns 1,531 shares of the conglomerate’s stock worth $426,000 after acquiring an additional 45 shares during the last quarter. Finally, Dakota Community Bank & Trust NA increased its position in shares of Danaher by 16.4% during the fourth quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock worth $73,000 after acquiring an additional 45 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 11.10% of the company’s stock.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This is a positive change from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.61%. Danaher’s dividend payout ratio (DPR) is 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.